- Home
- NHTC vs NRXP Comparison
NHTC vs NRXP Comparison
Compare NHTC & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NHTC | NRXP |
|---|---|---|
| Founded | 1988 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.9M | 54.2M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | NHTC | NRXP |
|---|---|---|
| Price | $3.19 | $1.85 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $31.50 |
| AVG Volume (30 Days) | 22.3K | ★ 487.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 12.95% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $39,776,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $847.91 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.40 | $1.58 |
| 52 Week High | $5.48 | $3.84 |
Technical Indicators
Market Signals| Indicator | NHTC | NRXP |
|---|---|---|
| Relative Strength Index (RSI) | 40.06 | 47.54 |
| Support Level | $2.99 | $1.65 |
| Resistance Level | $3.07 | $1.99 |
| Average True Range (ATR) | 0.14 | 0.10 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 13.16 | 53.97 |
Price Performance
Historical ComparisonAbout NHTC Natural Health Trends Corp.
Natural Health Trends Corp is an international direct-selling and e-commerce company. It offers a line of products such as Wellness, Herbal, Beauty, Lifestyle, and Home. Wellness products include targeted nutrition for joint health, antioxidant support, digestive health, heart health, and vision health. Herbal products include anti-aging and hydrating cleansers, creams, lotions, serums, and toners. Lifestyle products improve the overall quality of life and support active, physical, and healthy lifestyles. Home products are designed to create a clean and natural living environment for the home. It generates a majority of its revenue from Hong Kong and the rest from China, Taiwan, Japan, the United States, and other regions.
About NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.